Medpace Holdings Operating Income 2014-2025 | MEDP

Medpace Holdings annual/quarterly operating income history and growth rate from 2014 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Medpace Holdings operating income for the quarter ending June 30, 2025 was $0.126B, a 20.15% increase year-over-year.
  • Medpace Holdings operating income for the twelve months ending June 30, 2025 was $0.478B, a 25.18% increase year-over-year.
  • Medpace Holdings annual operating income for 2024 was $0.447B, a 32.67% increase from 2023.
  • Medpace Holdings annual operating income for 2023 was $0.337B, a 20.86% increase from 2022.
  • Medpace Holdings annual operating income for 2022 was $0.279B, a 40.32% increase from 2021.
Medpace Holdings Annual Operating Income
(Millions of US $)
2024 $447
2023 $337
2022 $279
2021 $199
2020 $167
2019 $127
2018 $101
2017 $65
2016 $52
2015 $21
2014 $4
2013 $59
Medpace Holdings Quarterly Operating Income
(Millions of US $)
2025-06-30 $126
2025-03-31 $114
2024-12-31 $125
2024-09-30 $112
2024-06-30 $105
2024-03-31 $104
2023-12-31 $87
2023-09-30 $85
2023-06-30 $78
2023-03-31 $86
2022-12-31 $76
2022-09-30 $78
2022-06-30 $60
2022-03-31 $64
2021-12-31 $55
2021-09-30 $54
2021-06-30 $42
2021-03-31 $48
2020-12-31 $55
2020-09-30 $46
2020-06-30 $30
2020-03-31 $36
2019-12-31 $36
2019-09-30 $30
2019-06-30 $35
2019-03-31 $26
2018-12-31 $31
2018-09-30 $27
2018-06-30 $23
2018-03-31 $20
2017-12-31 $15
2017-09-30 $17
2017-06-30 $16
2017-03-31 $16
2016-12-31 $13
2016-09-30 $13
2016-06-30 $14
2016-03-31 $13
2015-12-31
2015-09-30 $7
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $12.288B $2.109B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.699B 26.28
CVS Health (CVS) United States $78.241B 9.72
Elevance Health (ELV) United States $66.788B 8.98
Cencora (COR) United States $56.876B 19.79
DiDi Global (DIDIY) China $27.957B 29.70
Labcorp Holdings (LH) United States $20.968B 17.01
Natera (NTRA) United States $18.819B 0.00
BioMerieux (BMXMF) France $15.985B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.728B 0.00
ICON (ICLR) Ireland $13.558B 13.05
CochLear (CHEOY) Australia $13.493B 0.00
Solventum (SOLV) United States $12.872B 13.63
Revvity (RVTY) United States $11.722B 20.17
Viatris (VTRS) United States $10.997B 3.78
Avantor (AVTR) United States $9.267B 13.47
Sonic Healthcare (SKHHY) Australia $9.129B 0.00
HealthEquity (HQY) United States $8.380B 36.71
Charles River Laboratories (CRL) United States $8.249B 16.17
Caris Life Sciences,�Inc (CAI) United States $7.640B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.038B 29.67
BrightSpring Health Services (BTSG) United States $3.745B 34.35
Sotera Health (SHC) United States $3.364B 19.11
Surgery Partners (SGRY) United States $2.848B 37.03
Organon (OGN) United States $2.626B 2.79
Concentras Parent (CON) United States $2.584B 14.93
Alignment Healthcare (ALHC) United States $2.453B 0.00
GeneDx Holdings (WGS) United States $2.367B 91.15
Progyny (PGNY) United States $2.011B 44.26
PACS (PACS) United States $1.821B 0.00
GoodRx Holdings (GDRX) United States $1.800B 36.00
Premier (PINC) United States $1.761B 13.37
Ardent Health (ARDT) United States $1.582B 6.74
Teladoc Health (TDOC) United States $1.505B 0.00
Establishment Labs Holdings (ESTA) $1.249B 0.00
Pediatrix Medical (MD) United States $1.126B 8.57
QDM (QDMI) Hong Kong, SAR China $0.999B 342.50
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.948B 0.00
AMN Healthcare Services Inc (AMN) United States $0.786B 7.35
CareDx (CDNA) United States $0.731B 11.41
Embecta (EMBC) United States $0.680B 4.58
So-Young (SY) China $0.557B 0.00
InnovAge Holding (INNV) United States $0.540B 0.00
Nutex Health (NUTX) United States $0.516B 7.81
SBC Medicals (SBC) United States $0.510B 0.00
Omada Health (OMDA) $0.496B 0.00
LifeMD (LFMD) United States $0.493B 0.00
Sonida Senior Living (SNDA) United States $0.472B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
COMPASS Pathways (CMPS) United Kingdom $0.432B 0.00
Enhabit (EHAB) United States $0.350B 28.83
Oncology Institute (TOI) United States $0.331B 0.00
Performant Healthcare (PHLT) United States $0.295B 0.00
Beauty Health (SKIN) United States $0.255B 0.00
DocGo (DCGO) United States $0.159B 26.00
Pheton Holdings (PTHL) China $0.155B 0.00
Sera Prognostics (SERA) United States $0.117B 0.00
KindlyMD (NAKA) United States $0.084B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
Biodesix (BDSX) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
ModivCare (MODV) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.045B 0.00
Basel Medical Group (BMGL) Singapore $0.042B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00